DocDollars

Arcutis Biotherapeutics, Inc.

CA · United States · Reporting entity ID 100001351935

Total reported 2019–2025
$24.4M
#284 of 2,960 reporting companies — 0% of all reported industry payments
$17.3M in general payments across 142,262 records, plus $7.16M in research funding across 2,131 records.

How it breaks down

General payments $17,289,187
Research funding $7,156,696

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Arcutis Biotherapeutics, Inc. reported $24.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #284 of 2,960 reporting companies. 29% of that was research funding and 71% general payments such as consulting, speaking, food and travel. 142,262 general payment records and 2,131 research records were filed.

Common questions about Arcutis Biotherapeutics, Inc.

How much has Arcutis Biotherapeutics, Inc. paid US doctors?

Arcutis Biotherapeutics, Inc. reported $24,445,883 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $17,289,187 in general payments, $7,156,696 in research funding.

How does Arcutis Biotherapeutics, Inc. rank among drug and device companies?

It ranks #284 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Arcutis Biotherapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.